Boehringer Ingelheim Sees Lung Function Improvement In Tiotropium Phase III Trials
This article was originally published in PharmAsia News
Executive Summary
German company Boehringer Ingelheim announced positive results of its Phase III trials with bronchodilator Tiotropium for patients suffering from severe asthma.